Literature DB >> 27213625

The Effectiveness of Small-group Community-based Information Sessions on Clinical Trial Recruitment for Secondary Prevention of Alzheimer's Disease.

Sarah D Tarrant1, Shoshana H Bardach, Kendra Bates, Heather Nichols, Jacqueline Towner, Clay Tamatha, Allison Caban-Holt, Linda J Van-Eldik, Richard R Murphy, Reisa Sperling, Gregory A Jicha.   

Abstract

Effective and practical recruitment strategies are needed to ensure successful recruitment into the Alzheimer disease clinical trials. To facilitate successful recruitment for the NIH-sponsored A4 (Anti-Amyloid treatment in Asymptomatic Alzheimer's disease, NCT02008357) trial for the secondary prevention of Alzheimer disease, we developed a small-group community information session to attract and recruit potential research participants. After a successful media campaign, 213 participants were screened through telephone for eligibility, identifying 127 potential participants. Participants were given the option of a traditional one-on-one recruitment session or a small-group session. One-on-one recruitment was performed for 15 participants requesting this procedure, and yielded an overall recruitment rate of 67% (n=10). Substantially more individuals (n=112, 88%) requested small-group sessions to learn about the study. After attending the small-group informational sessions, 98% of potential participants self-reported a greater understanding of the study; and the recruitment rate from these sessions was 90%. Small-group sessions not only improved recruitment success rates, but also contributed to significantly shorter median time for consent processes (20 vs. 60 min) and reduced staff time spent on persons not recruited. Small-group education programs are an effective strategy for enhancing recruitment success and facilitating practical recruitment into clinical trials with high recruitment demands.

Entities:  

Mesh:

Year:  2017        PMID: 27213625      PMCID: PMC5116426          DOI: 10.1097/WAD.0000000000000151

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  14 in total

1.  Recruitment rates in gerontological research: the situation for drug trials in dementia may be worse than previously reported.

Authors:  J Cohen-Mansfield
Journal:  Alzheimer Dis Assoc Disord       Date:  2002 Oct-Dec       Impact factor: 2.703

2.  Recruitment, retention and other methodological issues related to clinical trials for Alzheimer's disease.

Authors:  B Vellas
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

3.  Beyond diversity to inclusion: recruitment and retention of diverse groups in Alzheimer research.

Authors:  Peggye Dilworth-Anderson; Monique D Cohen
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

Review 4.  Recruitment of subjects into clinical trials for Alzheimer disease.

Authors:  Janice A Knebl; Deepti Patki
Journal:  J Am Osteopath Assoc       Date:  2010-09

5.  AMPA workshop on challenges faced by investigators conducting Alzheimer's disease clinical trials.

Authors:  Bruno Vellas; Alain Pesce; Philippe H Robert; Paul S Aisen; Sonia Ancoli-Israel; Sandrine Andrieu; Jesse Cedarbaum; Bruno Dubois; Eric Siemers; Jean-Paul Spire; Michael W Weiner; Thomas S May
Journal:  Alzheimers Dement       Date:  2011-07       Impact factor: 21.566

6.  Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology.

Authors:  B Vellas; H Hampel; M E Rougé-Bugat; M Grundman; S Andrieu; S Abu-Shakra; R Bateman; R Berman; R Black; M Carrillo; M Donohue; M Mintun; J Morris; R Petersen; R G Thomas; J Suhy; L Schneider; L Seely; P Tariot; J Touchon; M Weiner; C Sampaio; P Aisen
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

Review 7.  Recruitment methods for United States Alzheimer disease prevention trials.

Authors:  L S Schneider
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

8.  Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial).

Authors:  I Carrié; G Abellan van Kan; S Gillette-Guyonnet; S Andrieu; J-F Dartigues; J Touchon; T Dantoine; O Rouaud; M Bonnefoy; P Robert; M-N Cuffi; L Bories; S Bordes; Y Gasnier; F Desclaux; K Sudres; A Pesce; B Vellas
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

9.  Research subject recruitment for gerontological studies of pharmacological agents.

Authors:  M I Levy; R C Mohs; W G Rosen; K L Davis
Journal:  Neurobiol Aging       Date:  1982       Impact factor: 4.673

10.  Comparison of recruitment efforts targeted at primary care physicians versus the community at large for participation in Alzheimer disease clinical trials.

Authors:  Sarah A Carr; Roberta Davis; Diane Spencer; Marie Smart; Joanna Hudson; Stephanie Freeman; Greg E Cooper; Fred A Schmitt; William R Markesbery; Deborah Danner; Gregory A Jicha
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Apr-Jun       Impact factor: 2.703

View more
  5 in total

1.  Recruiting the Oldest-old for Clinical Research.

Authors:  Zarui A Melikyan; Dana E Greenia; Maria M Corrada; Marilyn M Hester; Claudia H Kawas; Joshua D Grill
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Apr-Jun       Impact factor: 2.703

2.  Alzheimer Disease Clinical Trial Recruitment: Does Participation in a Brief Cognitive Screen at a Community Health Fair Promote Research Engagement?

Authors:  Justin M Barber; Shoshana H Bardach; Gregory A Jicha
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

3.  Evaluation of HbA1c screening during outreach events for prediabetes subject recruitment for clinical research.

Authors:  Sabina Paglialunga; Ryan Bond; Sharon H Jaycox
Journal:  Trials       Date:  2018-01-22       Impact factor: 2.279

4.  Quantifying Recruitment Source and Participant Communication Preferences for Alzheimer's Disease Prevention Research.

Authors:  D Julbe-Delgado; J L O'Brien; R Abdulkarim; E M Hudak; H Maeda; J D Edwards
Journal:  J Prev Alzheimers Dis       Date:  2021

5.  Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial.

Authors:  Rema Raman; Yakeel T Quiroz; Oliver Langford; Jiyoon Choi; Marina Ritchie; Morgan Baumgartner; Dorene Rentz; Neelum T Aggarwal; Paul Aisen; Reisa Sperling; Joshua D Grill
Journal:  JAMA Netw Open       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.